Literature DB >> 33664644

Effects of Alzheimer's and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer's Disease.

Wha Jin Lee1, Cindy W Yoon2, Sung-Woo Kim1, Hye Jin Jeong3, Seongho Seo4,5, Duk L Na6,7, Young Noh8,9, Joon-Kyung Seong1,10,11.   

Abstract

Early- and late-onset Alzheimer's disease (AD) patients often exhibit distinct features. We sought to compare overall white matter connectivity and evaluate the pathological factors (amyloid, tau, and vascular pathologies) that affect the disruption of connectivity in these two groups. A total of 50 early- and 38 late-onset AD patients, as well as age-matched cognitively normal participants, were enrolled and underwent diffusion-weighted magnetic resonance imaging to construct fractional anisotropy-weighted white matter connectivity maps. [18F]-THK5351 PET, [18F]-Flutemetamol PET, and magnetic resonance imaging were used for the evaluation of tau and related astrogliosis, amyloid, and small vessel disease markers (lacunes and white matter hyperintensities). Cluster-based statistics was performed for connectivity comparisons and correlation analysis between connectivity disruption and the pathological markers. Both patient groups exhibited significantly disrupted connectivity compared to their control counterparts with distinct patterns. Only THK retention was related to connectivity disruption in early-onset AD patients, and this disruption showed correlations with most cognitive scores, while late-onset AD patients had disrupted connectivity correlated with amyloid deposition, white matter hyperintensities, and lacunes in which only a few cognitive scores showed associations. These findings suggest that the pathogenesis of connectivity disruption and its effects on cognition are distinct between EOAD and LOAD.
Copyright © 2021 Lee, Yoon, Kim, Jeong, Seo, Na, Noh and Seong.

Entities:  

Keywords:  amyloid; early-onset AD; late-onset AD; positron emission tomography; small vessel disease; tau; white matter connectivity

Year:  2021        PMID: 33664644      PMCID: PMC7921324          DOI: 10.3389/fnins.2021.606600

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  67 in total

1.  Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.

Authors:  Rik Ossenkoppele; Marissa D Zwan; Nelleke Tolboom; Danielle M E van Assema; Sofie F Adriaanse; Reina W Kloet; Ronald Boellaard; Albert D Windhorst; Frederik Barkhof; Adriaan A Lammertsma; Philip Scheltens; Wiesje M van der Flier; Bart N M van Berckel
Journal:  Brain       Date:  2012-05-03       Impact factor: 13.501

2.  White matter hyperintensities predict amyloid increase in Alzheimer's disease.

Authors:  Timo Grimmer; Maximilian Faust; Florian Auer; Panagiotis Alexopoulos; Hans Förstl; Gjermund Henriksen; Robert Perneczky; Christian Sorg; Behrooz H Yousefi; Alexander Drzezga; Alexander Kurz
Journal:  Neurobiol Aging       Date:  2012-03-10       Impact factor: 4.673

3.  Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease.

Authors:  Hanna Cho; Jae Yong Choi; Seung Ha Lee; Jae Hoon Lee; Young-Chul Choi; Young Hoon Ryu; Myoung Sik Lee; Chul Hyoung Lyoo
Journal:  Neurobiol Aging       Date:  2017-02-09       Impact factor: 4.673

4.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

5.  A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.

Authors:  David E Hurtado; Laura Molina-Porcel; Michiyo Iba; Awo K Aboagye; Steven M Paul; John Q Trojanowski; Virginia M-Y Lee
Journal:  Am J Pathol       Date:  2010-08-27       Impact factor: 4.307

6.  Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease.

Authors:  Ryuichi Harada; Aiko Ishiki; Hideaki Kai; Naomi Sato; Katsutoshi Furukawa; Shozo Furumoto; Tetsuro Tago; Naoki Tomita; Shoichi Watanuki; Kotaro Hiraoka; Yoichi Ishikawa; Yoshihito Funaki; Tadaho Nakamura; Takeo Yoshikawa; Ren Iwata; Manabu Tashiro; Hironobu Sasano; Tetsuyuki Kitamoto; Kazuhiko Yanai; Hiroyuki Arai; Yukitsuka Kudo; Nobuyuki Okamura
Journal:  J Nucl Med       Date:  2017-09-01       Impact factor: 10.057

7.  Disruption of cerebral networks and cognitive impairment in Alzheimer disease.

Authors:  Yael D Reijmer; Alexander Leemans; Karen Caeyenberghs; Sophie M Heringa; Huiberdina L Koek; Geert Jan Biessels
Journal:  Neurology       Date:  2013-03-13       Impact factor: 9.910

8.  Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease.

Authors:  Michael Schöll; Rik Ossenkoppele; Olof Strandberg; Sebastian Palmqvist; Jonas Jögi; Tomas Ohlsson; Ruben Smith; Oskar Hansson
Journal:  Brain       Date:  2017-09-01       Impact factor: 13.501

9.  Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons.

Authors:  Elisa M Ramser; Kathlyn J Gan; Helena Decker; Emily Y Fan; Matthew M Suzuki; Sergio T Ferreira; Michael A Silverman
Journal:  Mol Biol Cell       Date:  2013-06-19       Impact factor: 4.138

10.  Involvement of the Precuneus/Posterior Cingulate Cortex Is Significant for the Development of Alzheimer's Disease: A PET (THK5351, PiB) and Resting fMRI Study.

Authors:  Takamasa Yokoi; Hirohisa Watanabe; Hiroshi Yamaguchi; Epifanio Bagarinao; Michihito Masuda; Kazunori Imai; Aya Ogura; Reiko Ohdake; Kazuya Kawabata; Kazuhiro Hara; Yuichi Riku; Shinsuke Ishigaki; Masahisa Katsuno; Shinichi Miyao; Katsuhiko Kato; Shinji Naganawa; Ryuichi Harada; Nobuyuki Okamura; Kazuhiko Yanai; Mari Yoshida; Gen Sobue
Journal:  Front Aging Neurosci       Date:  2018-10-05       Impact factor: 5.750

View more
  3 in total

1.  Unified framework for brain connectivity-based biomarkers in neurodegenerative disorders.

Authors:  Sung-Woo Kim; Yeong-Hun Song; Hee Jin Kim; Young Noh; Sang Won Seo; Duk L Na; Joon-Kyung Seong
Journal:  Front Neurosci       Date:  2022-09-20       Impact factor: 5.152

2.  Gender Differences in Demographic and Pharmacological Factors in Patients Diagnosed with Late-Onset of Alzheimer's Disease.

Authors:  Melissa J Bailey-Taylor; Nicolas Poupore; Laurie Theriot Roley; Richard L Goodwin; Brooks Mcphail; Thomas I Nathaniel
Journal:  Brain Sci       Date:  2022-01-26

3.  Progressive Vascular Abnormalities in the Aging 3xTg-AD Mouse Model of Alzheimer's Disease.

Authors:  Amandine Jullienne; Ryan Quan; Jenny I Szu; Michelle V Trinh; Erik J Behringer; Andre Obenaus
Journal:  Biomedicines       Date:  2022-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.